# Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)

> **NCT01296412** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 653 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** sitagliptin
- **DRUG:** liraglutide
- **DRUG:** glimepiride
- **DRUG:** metformin

## Key facts

- **NCT ID:** NCT01296412
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03-11
- **Primary completion:** 2012-02-29
- **Final completion:** 2012-02-29
- **Target enrollment:** 653 (ACTUAL)
- **Last updated:** 2017-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01296412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01296412, "Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01296412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*